Jack Gray

Representative experience as part of a team, including prior to joining Weil, includes acting for:

• Ares and Goldman Sachs on their participation in CD&R’s £9.7 billion offer for Wm Morrison Supermarkets Plc
• Ares on the refinancing of TalkTalk Telecom Group
• Atlas Mara on its strategic financing agreement with Fairfax Africa Holdings Corporation and the associated placing and open offer and on Atlas Mara’s transaction in Rwanda
• bd-capital on its acquisition of SportPursuit
• Berkshire Partners on numerous private equity transactions, including:
• the merger of VetStrategy with IVC
• the acquisition of the REPA Group
• the acquisition of a joint venture interest in MedOne
• Century Aluminum on its agreement with Noble Group to acquire Noble’s 55% ownership interest in Jamalco, a bauxite mining and alumina production joint venture in Jamaica
• Compagnie Financière Richemont S.A. on the all-share merger of The Net-A-Porter Group Limited and YOOX S.p.A to create the YOOX Net-A-Porter Group and on its acquisition of Watchfinder.co.uk
• CVC on its strategic partnership with Dale Underwriting Partners
• Dugout on its merger with OneFootball
• Eutelsat on its combination with OneWeb and its listing on the London Stock Exchange
• Financing banks to the acquirer on the UK public takeovers of each of RSA Insurance Group plc and Meggitt PLC
• General Atlantic on:
• the investment in Dixa
• its investment in the Permira and Blackstone-led take-private of Adevinta, valuing Adevinta at around NOK 141 billion
• its majority investment in GRESB
• its minority investment in Wireless Logic, valuing Wireless Logic at £3.5 billion
• Generation Investment Management on its equity investment of up to $600 million in Octopus Energy Group
• IBM on the sale of its Algorithmics Assets to SS&C Technologies Holdings, Inc.
• Marsh & McLennan Companies Inc. on the £4.3bn recommended cash acquisition of Jardine Lloyd Thompson Group plc
• KLAR Partners on the acquisition of Ventro Group
• Petropavlovsk Plc on M&A and corporate governance matters and on a variety of contentious and regulatory matters, including internal and external investigations
• Roivant Sciences on its strategic alliance with Sumitomo Dainippon Pharma
• Sanofi on its up to $1.45 billion acquisition of Kymab, Ltd.
• Standard Life Aberdeen plc on the £3.24bn sale of its UK and European insurance business to Phoenix Group Holdings
• Standard Life plc on the £11bn recommended all-share merger with Aberdeen Asset Management to create Standard Life Aberdeen plc
• Swiss Re Ltd on the sale of a minority stake in ReAssure to MS&AD Insurance Group Holdings, Inc.
• United Utilities Group plc on the formation of a new joint venture with Severn Trent plc
• Zurich Insurance plc on the transfer of its pre-2007 UK legacy employers’ liability portfolio to Catalina by way of an interim reinsurance arrangement and subsequent insurance business transfer